Genetic Signatures (GSS) Stock Overview

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.

GSS Stock Information

Symbol

GSS

Address

Heart Research InstituteNewtown, NSW 2042Australia

Founded

Trading hours

10:00 AM - 4:00 PM AEST

Website

https://www.geneticsignatures.com

Country

🇦🇺 Australia

Phone Number

61 2 9870 7580

Genetic Signatures (GSS) Price Chart

Genetic Signatures Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.4000650105642167	N/A
Market Cap	$65.98M	N/A
Shares Outstanding	164.92M	12.57%
Employees	0	N/A
Shareholder Equity	42.91M	-21.69%

Valuation	2023	Change
P/S Ratio	4.94	N/A
P/B Ratio	1.54	N/A

Growth	2023	Change
Return on Equity	-0.2047	N/A

Earnings	2023	Change
Revenue	$13.35M	N/A
Earnings	-$8.78M	N/A
Gross Margin	0.6257	N/A
Operating Margin	-0.6904	N/A
Net income margin	-0.6579	N/A

Financial Strength	2023	Change
Total Assets	$30.68M	N/A
Cash on Hand	$10.22M	N/A
Debt to Equity	0.0898	62.23%
Current Ratio	$5.99	-43.80%